Compare Oscar Health Inc (OSCR) vs Vertiv Holdings Co (VRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Vertiv Holdings Co — how do they compare? Oscar Health Inc trades at $33.4 (market cap $10.22B), while Vertiv Holdings Co trades at $242.8 (market cap $93.83B). The key difference: Vertiv Holdings Co is far larger — about 9.2× Oscar Health Inc's market cap, and Vertiv Holdings Co pays a 0.1% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Vertiv Holdings Co for 39 Days on average.
| OSCR | VRT | |
|---|---|---|
Market Cap | $10.22B | $93.83B |
Volume | 4,123,394 | 5,855,911 |
Sector | Health | Industrials |
52-Week High | $33.81 | $376.23 |
52-Week Low | $10.85 | $149.83 |
Typical Hold Time | 15 Days | 39 Days |
Enterprise Value | $6.57B | $94.06B |
Dividend Yield | — | 0.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Vertiv (VRT) trades at $242.78, down 1.51% on the day, amid a bearish technical signal but strong fundamental momentum. The stock benefits from robust earnings beats, with Q2 2026 EPS of $1.52 exceeding the $1.42 estimate, and revenue growth projections from $10.23B in 2025 to $11.5B in 2026. Analyst sentiment remains overwhelmingly bullish with a 95% buy rating and a $364.94 consensus price target, driven by AI data center demand for power and cooling solutions.
The outlook is positive given Vertiv's strategic positioning in AI infrastructure, though risks include potential securities law investigations noted in recent news and high valuation multiples like a P/E of 55.14. Investors should weigh the company's growth trajectory against execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →
